Try Alerts Free   |   Login
Health Care › BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

CGEM Price Correlated With Financials For Cullinan Oncology

Free historical financial statements for Cullinan Oncology Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 5 quarters since 2021. Compare with CGEM stock chart to see long term trends.

CGEM Stock Compared to Quarterly

CGEM Income Statement

Revenue, Net:0
Revenue Per Share:0
Selling, General & Admin Expense:8121000
Research & Development Expense:24536000
Total Operating Expenses:32657000
Operating Income:-32657000
Income Taxes:-19568000
Net Income:-12892000
Earnings Per Share, Basic:-0.27
Shares Outstanding, Basic Avg:44782502

CGEM Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:13000
Net Cash from Operations:-21908000
Net Cash from Operations Per Share:-0.4892
Net Cash from Financing Activities:3541000
Net Cash from Investing Activities:34711000
Net Change in Cash & Equivalents:16344000

CGEM Balance Sheet

Cash and Cash Equivalents:76118000
Short-Term Investments:238736000
Total Current Assets:322312000
Property, Plant & Equipment, Net:64000
Total Assets:437463000
Accounts Payable:6306000
Total Short-Term Liabilities:17257000
Total Liabilities:17993000

Insider Trading

 
Change
Value
Transaction
SEC Form 4
AHMED NADIM   President and CEO
8,090 sh at $12
$100,316
Buy
BVF PARTNERS L P/IL   10% Owner
751,396 sh at $11
$8,264,905
Buy
BVF PARTNERS L P/IL   10% Owner
1,109,900 sh at $9
$10,063,937
Buy
BVF PARTNERS L P/IL   10% Owner
276,000 sh at $11
$2,966,972
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Mpm Oncology Impact Management Lp
7,648,268 sh
 
$80,077
Vanguard Group Inc
2,352,125 sh
-14,683 sh
-1%
$24,626
-$11,894
Blackrock Inc.
1,826,169 sh
-12,943 sh
-1%
$19,120
-$9,259
FMR LLC
1,629,180 sh
689,140 sh
73%
$17,057
$2,552
Baupost Group LLC
1,535,560 sh
 
$16,077
American International Group Inc
1,236,560 sh
-904 sh
0%
$12,947
-$6,147
Foresite Capital Management V, LLC
992,507 sh
-150,499 sh
-13%
$10,392
-$7,245
Franklin Resources Inc
777,880 sh
3,346 sh
0%
$8,144
-$3,807
Morgan Stanley
497,875 sh
168,419 sh
51%
$5,213
$129
Geode Capital Management, LLC
442,541 sh
10,670 sh
2%
$4,633
-$2,030
Foresite Capital Opportunity Management V, LLC
330,836 sh
-50,166 sh
-13%
$3,464
-$2,415
Artal Group S.A.
250,000 sh
 
$2,618
Northern Trust Corp
238,943 sh
7,560 sh
3%
$2,502
-$1,069
Charles Schwab Investment Management Inc
178,150 sh
3,937 sh
2%
$1,866
-$823
UBS Group Ag
124,909 sh
103,167 sh
475%
$1,307
$971
Bank Of New York Mellon Corp
93,184 sh
-2,239 sh
-2%
$975
-$498
Rafferty Asset Management, LLC
55,152 sh
-15,987 sh
-22%
$577
-$521
Birchview Capital, Lp
45,114 sh
 
$472
Swiss National Bank
36,200 sh
2,700 sh
8%
$379
-$138
State Of Wisconsin Investment Board
34,700 sh
17,600 sh
103%
$363
$99

Data imported from Cullinan Oncology Inc. SEC filings. Check original filings before making any investment decision.